| Name | Title | Contact Details |
|---|
For decades, entrenched infrastructure barriers have slowed progress in the fight against cancer and the development of potent immunotherapies. The Parker Institute for Cancer Immunotherapy breaks down these barriers. The result is groundbreaking new research and an intellectual property model that builds collaboration between researchers, nonprofits and industry all working together to get treatments to patients faster.
Portola Pharmaceuticals is dedicated to developing and commercializing therapies that transform patient lives and advance patient care by changing treatment paradigms in thrombosis and other hematologic diseases. Our two lead assets are Bevyxxa® (betrixaban), and andexanet alfa. In addition, cerdulatinib is our investigational Syk/JAK inhibitor to treat hematologic cancers. These compounds come from our own internal research efforts and represent important advances to address significant unmet needs. We are employing novel strategies that may increase the likelihood of clinical, regulatory and commercial success of our potentially lifesaving therapies.
Test Equipment Distributors is a Troy, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Cancer Expert Now`s services connect you to distinguished experts to discuss current disease challenges, recent literature, global clinical findings, and even share their research and experience in the context of your specific diagnosis, or patient cases.
Accu-Med Services is a Milford, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.